Alphatec/$ATEC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Alphatec
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
Ticker
$ATEC
Sector
Primary listing
Employees
867
Headquarters
Website
Alphatec Metrics
BasicAdvanced
$2.2B
-
-$1.14
1.03
-
Price and volume
Market cap
$2.2B
Beta
1.03
52-week high
$16.70
52-week low
$4.88
Average daily volume
2.2M
Financial strength
Current ratio
2.875
Quick ratio
1.641
Long term debt to equity
1,242.739
Total debt to equity
1,238.293
Interest coverage (TTM)
-2.81%
Profitability
EBITDA (TTM)
-15.01
Gross margin (TTM)
68.78%
Net profit margin (TTM)
-24.33%
Operating margin (TTM)
-13.91%
Effective tax rate (TTM)
-0.18%
Revenue per employee (TTM)
$790,000
Management effectiveness
Return on assets (TTM)
-7.61%
Return on equity (TTM)
-376.89%
Valuation
Price to revenue (TTM)
3.15
Price to book
90.93
Price to tangible book (TTM)
-14.7
Price to free cash flow (TTM)
-67.752
Free cash flow yield (TTM)
-1.48%
Free cash flow per share (TTM)
-0.217
Growth
Revenue change (TTM)
26.27%
Earnings per share change (TTM)
-15.24%
3-year revenue growth (CAGR)
32.71%
10-year revenue growth (CAGR)
14.74%
3-year earnings per share growth (CAGR)
-11.21%
10-year earnings per share growth (CAGR)
-4.16%
What the Analysts think about Alphatec
Analyst ratings (Buy, Hold, Sell) for Alphatec stock.
Bulls say / Bears say
Alphatec’s total revenue for Q2 2025 increased by 27.5% to $186 million, beating analysts’ forecast of $178.8 million, driven by a 29% rise in surgical revenue to $168 million.
Adjusted EBITDA for Q2 reached $23 million, outpacing the consensus estimate of $17.8 million and showing strong operational discipline.
The company raised its full-year 2025 revenue guidance to $742 million, up 21%, and lifted adjusted EBITDA guidance to $83 million, reflecting confidence in its ongoing momentum.
Despite posting non-GAAP profitability, Alphatec reported a GAAP net loss of $41 million in Q2 2025, showing the company depends on adjustments to deliver positive earnings.
Operating income stayed negative at $13.08 million for the quarter, underlining persistent high operating costs which could challenge profitability if growth slows.
Alphatec shares dropped 10.4% after hours following the announcement of a $300 million, five-year convertible bond offering, signaling investors’ worries about possible dilution.
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2025.
Alphatec Financial Performance
Revenues and expenses
Alphatec Earnings Performance
Company profitability
Alphatec News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Alphatec stock?
Alphatec (ATEC) has a market cap of $2.2B as of September 18, 2025.
What is the P/E ratio for Alphatec stock?
The price to earnings (P/E) ratio for Alphatec (ATEC) stock is 0 as of September 18, 2025.
Does Alphatec stock pay dividends?
No, Alphatec (ATEC) stock does not pay dividends to its shareholders as of September 18, 2025.
When is the next Alphatec dividend payment date?
Alphatec (ATEC) stock does not pay dividends to its shareholders.
What is the beta indicator for Alphatec?
Alphatec (ATEC) has a beta rating of 1.03. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.